An extremely interesting research question abutting cardiac physiology, and a manuscript that may generate future additional clinical research.
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
October 14, 2019
September 27, 2019
Interesting to see the long term curative results of this randomized controlled trial.
September 25, 2019
Find it here: the Second International Conference on Sublobar Resections for Lung Cancer live on CTSNet.
September 25, 2019
This video demonstrates the authors’ experience performing a left pneumonectomy using the biportal VATS approach.
Prediction of Response to Anti-PD-1 Therapy in Patients With Non-small-cell Lung Cancer by Electronic Nose Analysis of Exhaled Breath
September 20, 2019
Immune checkpoint inhibitors have revolutionized treatment of non-small cell lung cancer. In this study, breath prophiles were collected from 143 patients and a single biomarker profile was created that detected responses to anti-PD-1 treatment with 89% accuracy.
September 19, 2019
Federico Venuta of the University of Rome in Italy presents a discussion on surgery for invasive lung cancer.
September 5, 2019
Paul E. Van Schil of Antwerp University Hospital in Belgium presents a discussion on the current status of the management of mesothelioma.
Video-Assisted Thoracoscopic Lobectomy for Giant Congenital Bulla of the Left Upper Lobe: A Case Report
August 26, 2019
This video demonstrates a left upper lobectomy via video-assisted thoracic surgery to treat a giant congenital bulla.
August 23, 2019
Egyud and colleagues evaluated plasma levels of circulating tumor (ct)DNA in patients with esophageal adenocarcinoma, ranging from stage I to stage IV. The quantity of ctDNA and likelihood of ctDNA detection was greater at later stages, suggesting that it may be challenging to use for early-stage diagnosis.
August 22, 2019
In this multiinstitutional retrospective study, administration of adjuvant chemotherapy for patients with persistent nodal disease after induction therapy and esophagectomy was associated with improved survival.